HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sergio H Marshall Selected Research

MicroRNAs (MicroRNA)

1/2021Expression of ssa-miR-155 during ISAV infection in vitro: Putative role as a modulator of the immune response in Salmo salar.
10/2018Involvement of selected cellular miRNAs in the in vitro and in vivo infection of infectious salmon anemia virus (ISAV).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sergio H Marshall Research Topics

Disease

11Infections
07/2021 - 11/2002
3Piscirickettsiaceae Infections
12/2023 - 05/2011
3Virus Diseases (Viral Diseases)
01/2021 - 01/2012
2Bacterial Infections (Bacterial Infection)
01/2018 - 05/2011

Drug/Important Bio-Agent (IBA)

3Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 05/2011
3Peptides (Polypeptides)IBA
07/2020 - 05/2011
2MicroRNAs (MicroRNA)IBA
01/2021 - 10/2018
2Proteins (Proteins, Gene)FDA Link
01/2018 - 03/2016
1Quillaja SaponinsIBA
07/2021
1SaponinsIBA
07/2021
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
12/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2016
1hemagglutinin esteraseIBA
04/2016
1Antiviral Agents (Antivirals)IBA
04/2016
1Interleukin-12 (IL 12)IBA
01/2016
1Interleukin-10 (Interleukin 10)IBA
01/2016
1ClathrinIBA
01/2015
1Type IV Secretion SystemsIBA
01/2015
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2013
1RNA (Ribonucleic Acid)IBA
01/2012
1flumequineIBA
05/2011
1florfenicolIBA
05/2011
1Oxolinic AcidIBA
05/2011
1Peptide Elongation Factors (Elongation Factor)IBA
04/2010
1TubulinIBA
04/2010
1UbiquitinIBA
04/2010
1Oxidoreductases (Dehydrogenase)IBA
04/2010
1Actins (F Actin)IBA
04/2010
1VaccinesIBA
11/2002
1Neutralizing AntibodiesIBA
11/2002

Therapy/Procedure

1Therapeutics
01/2012